StreetInsider.com News Articles

Form 144 CHEMED CORP Filed by: MCNAMARA KEVIN J

Thu, 12 Mar 2026 15:29:00 -0400

si-local-file:///var/storage/secattach/20260312/26152584.html

Form 144 CHEMED CORP Filed by: MCNAMARA KEVIN J

Thu, 12 Mar 2026 15:29:00 -0400

si-local-file:///var/storage/secattach/20260312/26152584.html

Form 144 CHEMED CORP Filed by: MCNAMARA KEVIN J

Thu, 12 Mar 2026 13:28:00 -0400

si-local-file:///var/storage/secattach/20260312/26152034.html

Form 144 CHEMED CORP Filed by: MCNAMARA KEVIN J

Thu, 12 Mar 2026 13:28:00 -0400

si-local-file:///var/storage/secattach/20260312/26152034.html

Chemed Corporation to Present at the Oppenheimer 36th Annual Healthcare Conference

Thu, 12 Mar 2026 12:00:00 -0400

CINCINNATI, March 12, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will deliver a virtual presentation at the Oppenheimer 36th Annual Healthcare Conference on Thursday, March 19, 2026, at approximately 9:20 a.m. (ET).

The virtual presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of the live presentation and will be accessible for 90 days.

Listed on the New York Stock Exchange and headquartered in Cincinnati,

Chemed Corporation to Present at the Oppenheimer 36th Annual Healthcare Conference

Thu, 12 Mar 2026 12:00:00 -0400

Listed on the New York Stock Exchange and headquartered in Cincinnati,

Form 10-K CHEMED CORP For: Dec 31

Fri, 27 Feb 2026 09:37:00 -0400

http://archive.fast-edgar.com/20260227/AP22B22CZ223D2O2222M22O2PBNA8Z227282

Filed on: February 27, 2026

Form 10-K CHEMED CORP For: Dec 31

Fri, 27 Feb 2026 09:37:00 -0400

http://archive.fast-edgar.com/20260227/AP22B22CZ223D2O2222M22O2PBNA8Z227282

Filed on: February 27, 2026

RBC Capital Downgrades Chemed (CHE) to Sector Perform

Fri, 27 Feb 2026 02:37:42 -0400

RBC Capital analyst Ben Hendrix downgraded Chemed (NYSE: CHE) from Outperform to Sector Perform with a price target of $422.00 (from $572.00).

The analyst comments: "We are stepping to the sidelines and downgrading CHE to Sector Perform over near and longer-term Roto-Rooter margin uncertainty, though we remain encouraged by VITAS' momentum, particularly within Florida. We believe ongoing headwinds impacting Roto-Rooter may begin to mask value in VITAS as the hospice segment rebalances LOS mix over the course of the year, potentially heightening investor interest in a separation transaction. We are downgrading to Sector Perform (previously Outperform) and lowering our price target

RBC Capital Downgrades Chemed (CHE) to Sector Perform

Fri, 27 Feb 2026 02:37:42 -0400

RBC Capital analyst Ben Hendrix downgraded Chemed (NYSE: CHE) from Outperform to Sector Perform with a price target of $422.00 (from $572.00).

Chemed Corporation Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Thu, 26 Feb 2026 17:18:00 -0400

SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Chemed Corporation (NYSE: CHE). The investigation focuses on Chemed’s executive officers and whether investor losses may be recovered under federal securities laws.

What if I purchased Chemed securities?

If you purchased Chemed securities and suffered losses on your investment, join our investigation now: Click here to join the investigation.
Or for more information, contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471.
There is no cost or obligation to you.

Background of

Chemed Corporation Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Thu, 26 Feb 2026 17:18:00 -0400

SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Chemed Corporation (NYSE: CHE). The investigation focuses on Chemed’s executive officers and whether investor losses may be recovered under federal securities laws.

What if I purchased Chemed securities?

If you purchased Chemed securities and suffered losses on your investment, join our investigation now: Click here to join the investigation.
Or for more information, contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471.
There is no cost or obligation to you.

Background of

Chemed Corporation Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Thu, 26 Feb 2026 17:18:00 -0400

SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Chemed Corporation (NYSE: CHE). The investigation focuses on Chemed’s executive officers and whether investor losses may be recovered under federal securities laws.

What if I purchased Chemed securities?

If you purchased Chemed securities and suffered losses on your investment, join our investigation now: Click here to join the investigation.
Or for more information, contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471.
There is no cost or obligation to you.

Background of

Chemed Corporation Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Thu, 26 Feb 2026 17:18:00 -0400

SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Chemed Corporation (NYSE: CHE). The investigation focuses on Chemed’s executive officers and whether investor losses may be recovered under federal securities laws.

What if I purchased Chemed securities?

If you purchased Chemed securities and suffered losses on your investment, join our investigation now: Click here to join the investigation.
Or for more information, contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471.
There is no cost or obligation to you.

Background of

BofA Securities Downgrades Chemed (CHE) to Neutral Following Earnings

Thu, 26 Feb 2026 09:46:27 -0400

BofA Securities analyst Joanna Gajuk downgraded Chemed (NYSE: CHE) from Buy to Neutral with a price target of $450.00 (from $595.00).
The analyst comments "Q4 EBITDA missed and 2026 EBITDA guide is 6% below expectations on much worse Roto-Rooter outlook. The Roto EBITDA declined for 3 years in a row and the company missed its initial guide, leaving us cautious on the 2026 guide and ability to grow that biz. The competition is not easing up and it appears new issues keep popping up. The worse Roto outlook is offset by Vitas being more stable, with a more sustainable growth (aging,

BofA Securities Downgrades Chemed (CHE) to Neutral Following Earnings

Thu, 26 Feb 2026 09:46:27 -0400

BofA Securities analyst Joanna Gajuk downgraded Chemed (NYSE: CHE) from Buy to Neutral with a price target of $450.00 (from $595.00).
The analyst comments "Q4 EBITDA missed and 2026 EBITDA guide is 6% below expectations on much worse Roto-Rooter outlook. The Roto EBITDA declined for 3 years in a row and the company missed its initial guide, leaving us cautious on the 2026 guide and ability to grow that biz. The competition is not easing up and it appears new issues keep popping up. The worse Roto outlook is offset by Vitas being more stable, with a more sustainable growth (aging,

Form 8-K CHEMED CORP For: Feb 25

Wed, 25 Feb 2026 16:31:00 -0400
si-local-file:///var/storage/secattach/20260225/26060691.html

Form 8-K CHEMED CORP For: Feb 25

Wed, 25 Feb 2026 16:31:00 -0400
si-local-file:///var/storage/secattach/20260225/26060691.html

Chemed Reports Fourth-Quarter 2025 Results

Wed, 25 Feb 2026 16:15:00 -0400

CINCINNATI, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its fourth quarter ended December 31, 2025, versus the comparable prior-year period.

Results for Quarter Ended December 31, 2025

Consolidated operating results:

Revenue was $639.3 million, essentially flat with the fourth quarter of 2024
GAAP Diluted Earnings-per-Share (EPS) of $5.48, a decrease of 9.0%
Adjusted Diluted EPS of

Chemed Reports Fourth-Quarter 2025 Results

Wed, 25 Feb 2026 16:15:00 -0400

CINCINNATI, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its fourth quarter ended December 31, 2025, versus the comparable prior-year period.

Results for Quarter Ended December 31, 2025

Consolidated operating results:

Revenue was $639.3 million, essentially flat with the fourth quarter of 2024
GAAP Diluted Earnings-per-Share (EPS) of $5.48, a decrease of 9.0%
Adjusted Diluted EPS of

Form 4 CHEMED CORP For: Feb 13 Filed by: LEE SPENCER S

Tue, 17 Feb 2026 16:50:00 -0400
si-local-file:///var/storage/secattach/20260217/26014559.html

Form 4 CHEMED CORP For: Feb 13 Filed by: LEE SPENCER S

Tue, 17 Feb 2026 16:50:00 -0400
si-local-file:///var/storage/secattach/20260217/26014559.html

Form 4 CHEMED CORP For: Feb 13 Filed by: HUTTON THOMAS C

Tue, 17 Feb 2026 16:37:00 -0400
si-local-file:///var/storage/secattach/20260217/26014076.html

Form 4 CHEMED CORP For: Feb 13 Filed by: HUTTON THOMAS C

Tue, 17 Feb 2026 16:37:00 -0400
si-local-file:///var/storage/secattach/20260217/26014076.html

Form 4 CHEMED CORP For: Feb 13 Filed by: Wherley Joel L

Tue, 17 Feb 2026 15:59:00 -0400
si-local-file:///var/storage/secattach/20260217/26011960.html